Powered by

Teva strikes another Allergan deal

Aug 03, 2016 - The Deal Pipeline
Board and Executive Moves-Mergers and Acquisitions

A day after sealing its largest purchase ever, Teva Pharmaceutical Industries Ltd. (TEVA) said Wednesday, Aug. 3, it has agreed to shell out $500 million for Allergan plc (AGN)'s Anda Inc., the fourth-largest distributor of generic pharmaceuticals in the U.S. 

The announcement comes just one day after Dublin-headquartered Allergan disclosed the completion of the sale of its generic drug business to Teva following a lengthy regulatory review process, through wh...